preview: fda approvals in cll and all, nda accepted in melanoma, and more
Published 7 years ago • 17 plays • Length 0:31
Download video MP4
Download video MP3
Similar videos
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
9:18
fda approval in melanoma, priority reviews in aml and wm, ndas in melanoma and sclc, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
24:22
highlight of cll-related 2016 fda approvals: venetoclax
-
9:46
fda approval in cll, recommendation in nsclc, missed endpoint in gbm study, and more
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
10:00
fda approvals in hnscc and dlbcl, and encouraging data in cll, mds, and cmml
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
11:34
fda approval in cll, recommendation in sts, partial hold on cervical cancer trial, and more
-
7:57
fda approvals in breast cancer and melanoma, disappointing results in hnscc, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
Clip.africa.com - Privacy-policy